Kilitch Drugs (India) Ltd
BSE:
NSE:KILITCH
KILITCH Share Price
BSE:
NSE:KILITCH
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹535.38Cr
PE Ratio
32.51
Kilitch Drugs (India) Ltd Performance
▲
▲
▲
▲
Kilitch Drugs (India) Ltd Fundamentals
Kilitch Drugs (India) Ltd Delivery and Volume
About Kilitch Drugs (India) Ltd
Kilitch Drugs (India) Limited (KDIL), incorporated in May, 1992 is the one of the leading and fastest growing pharmaceutical companies in the world, manufacturing, supplying and marketing broad range of pharmaceutical formulations in the various dosage forms like Solid, Liquid and Parental across th
| Name | Designation |
|---|---|
| Mukund P Mehta | Chairman & Managing Director |
| Bhavin M Mehta | Whole-time Director |
| Hemang Engineer | Independent Director |
| Mira Bhavin Mehta | Managing Director |
| Murti Vasudev Krishna | Independent Director |
| Venkita Subramanian Rajan | Independent Director |
| Pushpa Nyoupane | Company Sec. & Compli. Officer |
| Dipen Jayantilal Jain | Independent Director |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Kilitch Drugs (India) Ltd FAQs
How do I Buy Kilitch Drugs (India) Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Kilitch Drugs (India) Ltd shares in BlinkX.
What is the Share Price of Kilitch Drugs (India) Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Kilitch Drugs (India) Ltd's share price is ₹331.75 as of 2025-01-14.
What is the PE ratio of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd's P/E ratio is 32.51 times as of 2025-01-14.
What is the PB ratio of Kilitch Drugs (India) Ltd?
Kilitch Drugs (India) Ltd's most recent financial reports indicate a price-to-book ratio of 2.83, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Kilitch Drugs (India) Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Kilitch Drugs (India) Ltd's market capitalization is ₹535.38 Cr as on 2025-01-14.
What is the ROE of Kilitch Drugs (India) Ltd?
The current financial records of Kilitch Drugs (India) Ltd show a 8.39% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Kilitch Drugs (India) Ltd?
According to Kilitch Drugs (India) Ltd's most recent financial filings, the company has a total asset value of ₹94.62, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Kilitch Drugs (India) Ltd?
The 52-week high/low price of a Kilitch Drugs (India) Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Kilitch Drugs (India) Ltd's 52-week high and low as of 2025-01-14 are ₹333 and ₹319.2, respectively.
